SR
Saravanan Ramakrishnan Ellamanpettai
About Saravanan Ramakrishnan Ellamanpettai
Data last updated:
Saravanan Ramakrishnan Ellamanpettai is a Whole-Time Director at Innovative Therapeutics Private Limited (since 2006) and Director at Invocare Medtech Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹47.93 Cr; the largest is Innovative Therapeutics Private Limited at ₹46.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 26 Jun 2006 | 2006 | ₹46.75 Cr (FY 2025) | Active | |
| Director | 13 Jun 2020 | 2020 | ₹1.19 Cr (FY 2025) | Active |
Board colleagues of Saravanan Ramakrishnan Ellamanpettai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sasirekha Chinnadurai | 02708417 | Innovative Therapeutics Private Limited , Invocare Medtech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saravanan Ramakrishnan Ellamanpettai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saravanan Ramakrishnan Ellamanpettai
Saravanan Ramakrishnan Ellamanpettai currently holds 2 directorships: Innovative Therapeutics Private Limited (Whole-Time Director, since 26 Jun 2006, revenue ₹46.75 Cr (FY 2025)); Invocare Medtech Private Limited (Director, since 13 Jun 2020, revenue ₹1.19 Cr (FY 2025)).
Saravanan Ramakrishnan Ellamanpettai was first appointed on 26 Jun 2006 as Whole-Time Director at Innovative Therapeutics Private Limited. The most recent appointment on record is 13 Jun 2020 at Invocare Medtech Private Limited.
The 2 current companies of Saravanan Ramakrishnan Ellamanpettai that report revenue have a combined latest revenue of ₹47.93 Cr: Innovative Therapeutics Private Limited ₹46.75 Cr (FY 2025); Invocare Medtech Private Limited ₹1.19 Cr (FY 2025).
The current boards of Saravanan Ramakrishnan Ellamanpettai's companies include Sasirekha Chinnadurai (Innovative Therapeutics Private Limited).